Copyright
©The Author(s) 2022.
World J Hepatol. Apr 27, 2022; 14(4): 744-753
Published online Apr 27, 2022. doi: 10.4254/wjh.v14.i4.744
Published online Apr 27, 2022. doi: 10.4254/wjh.v14.i4.744
Table 2 Table summarizing distribution of fibrosis stages over two groups of ages
| Patient’s age | Fibrosis stages | |||||
| F0 | F0-F1 | F2-F3 | F3-F4 | F4 | Total | |
| 20-49 | 17 | 7 | 7 | 0 | 2 | 33 |
| > 50 | 12 | 6 | 7 | 5 | 10 | 40 |
| Total | 29 | 13 | 14 | 5 | 12 | 73 |
- Citation: Al Danaf L, Hussein Kamareddine M, Fayad E, Hussain A, Farhat S. Correlation between Fibroscan and laboratory tests in non-alcoholic fatty liver disease/non-alcoholic steatohepatitis patients for assessing liver fibrosis. World J Hepatol 2022; 14(4): 744-753
- URL: https://www.wjgnet.com/1948-5182/full/v14/i4/744.htm
- DOI: https://dx.doi.org/10.4254/wjh.v14.i4.744